| Healthcare Quality | Elective Percutaneous Coronary Intervention (PCI) Program Reports, 2023 | Q1 2024 |
| Healthcare Quality | Hospital Performance Ratings Summary | Q1 2024 |
| Healthcare Workforce | Languages Spoken by Patients and Hospital-based Providers in California | Q2 2024 |
| Healthcare Utilization | Inpatient Hospitalizations and Emergency Department Visits for Patients with a Behavioral Health Diagnosis in California: Patient Demographics | Q2 2024 |
| Cost Transparency | Net Patient Revenue, Discharges, and Outpatient Visits by Payer and Facility, 2019 | Q2 2024 |
| Cost Transparency | Healthcare Payments Data (HPD) Data Snapshot | Q3 2024 |
| Healthcare Utilization | Inpatient Hospitalizations and Emergency Department Visits for Persons Experiencing Homelessness in California: Patient Demographics By Facility | Q2 2024 |
| Healthcare Utilization | California Diagnostic Catheterization Volume and Sociodemographic Comparisons | Q2 2024 |
| Healthcare Workforce | Physician Supply and Preventable Hospitalizations by County | Q2 2024 |
| Healthcare Quality | California Transcatheter Aortic Valve Replacement (TAVR) Outcomes Report, 2022 | Q2 2024 |
| Healthcare Quality | Inpatient Mortality Indicators | Q2 2024 |
| Healthcare Utilization | Preferred Languages Spoken in California Facilities | Q3 2024 |
| Cost Transparency | Healthcare Payments Data (HPD) – Health Conditions, Demographics, Utilization Measure | Q3 2024 |
| Healthcare Quality | Effects of COVID-19 on Hospital Utilization Trends | Q3 2024 |
| Healthcare Quality/ Healthcare Utilization | 2023 Patient Discharge, Emergency Department, and Ambulatory Surgery Data | Q3 2024 |
| Cost Transparency | Wholesale Acquisition Cost (WAC) Increase Report Data – Cumulative | Q3 2024 |
| Cost Transparency | Wholesale Acquisition Cost (WAC) Increase Report Data – Current Year | Q3 2024 |
| Cost Transparency | Prescription Drugs Introduced to Market | Q3 2024 |
| Healthcare Quality | Mental and Behavioral Health Diagnoses in Emergency Department and Inpatient Discharges by Healthy Places Index Ranking | Q3 2024 |
| Healthcare Quality | Coronary Artery Bypass Graft (CABG): Hospital Performance Ratings, 2022 | Q3 2024 |
| Healthcare Quality | California Postoperative Sepsis Outcomes for Inpatient Elective Surgeries | Q3 2024 |
| Healthcare Utilization | Alcohol-Related Emergency Department Encounters in California | Q3 2024 |
| Healthcare Workforce | California’s Registered Nurse Education Pathways | Q4 2024 |
| Healthcare Workforce | Race & Ethnicity of California’s Health Workforce | Q4 2024 |
| Healthcare Workforce | Census Languages Spoken by California’s Health Workforce | Q4 2024 |
| Healthcare Workforce | California’s Health Workforce Education Pathways | Q4 2024 |
| Healthcare Quality | Social Drivers of Health (SDoH) and Preventable Hospitalization Rates | Q4 2024 |
| Cost Transparency | Wholesale Acquisition Cost Trends for Prescription Drugs and Their Therapeutic Equivalents | Q4 2024 |
| Healthcare Quality | Maternity Care Honor Roll, 2024 | Q4 2024 |
| Healthcare Quality | Pediatric Quality Indicators (PDIs)- Area Level 14 Asthma Admission Rate, 16 Gastroenteritis Admission Rate, 18 Urinary Tract Infection Admission Rate, 90 Pediatric Quality Overall Composite (area level) | Q4 2024 |
| Healthcare Quality | Hospitalizations for Severe Sepsis in California | Q4 2024 |
| Healthcare Utilization | Facility Patient Flow: Where Did Patients Come From, How Long Did They Stay and Where Did They Go? | Q4 2024 |
| Healthcare Utilization | Emergency Department Volume and Capacity by Facility, Health Category and Health Professional Shortage Area | Q4 2024 |
| Healthcare Utilization | All-Cause Unplanned 30-Day Hospital Readmission Rate, California – Let’s Get Healthy California (LGHC Indicator) | Q4 2024 |
| Healthcare Quality | Agency for Healthcare Research and Quality (AHRQ) utilizations (IQI 21, IQI 22, and IQI33) | Q4 2024 |
